Literature DB >> 12114043

How practical are recommendations for dietary control in phenylketonuria?

J H Walter1, F J White, S K Hall, A MacDonald, G Rylance, A Boneh, D E Francis, G J Shortland, M Schmidt, A Vail.   

Abstract

In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these aims are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control in phenylketonuria, especially in older rather than younger children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114043     DOI: 10.1016/s0140-6736(02)09334-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  97 in total

1.  Family conditions and dietary control in IEMs.

Authors:  Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2007-10       Impact factor: 4.982

Review 2.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

3.  'Ready to drink' protein substitute is easier is for people with phenylketonuria.

Authors:  A MacDonald; M Lilburn; P Davies; S Evans; A Daly; S K Hall; C Hendriksz; A Chakrapani; P Lee
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

4.  Nutritional Management of Phenylketonuria.

Authors:  Erin L Macleod; Denise M Ney
Journal:  Ann Nestle Eng       Date:  2010-06

5.  Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.

Authors:  Priscila Nicolao Mazzola; Melaine Terra; Andrea Pereira Rosa; Caroline Paula Mescka; Tarsila Barros Moraes; Bruna Piccoli; Carlos Eduardo Jacques; Giovana Dalazen; Marcelo Xavier Cortes; Juliana Coelho; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2011-09-27       Impact factor: 3.584

Review 6.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

7.  Family conditions and dietary control in phenylketonuria.

Authors:  G M Olsson; S M Montgomery; J Alm
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

8.  Management of adult patients with phenylketonuria: survey results from 24 countries.

Authors:  Friedrich K Trefz; Francjan J van Spronsen; Anita MacDonald; François Feillet; Ania C Muntau; Amaya Belanger-Quintana; Alberto Burlina; Mübeccel Demirkol; Marcello Giovannini; Christoph Gasteyger
Journal:  Eur J Pediatr       Date:  2014-12-06       Impact factor: 3.183

9.  Quality of life in noncompliant adults with phenylketonuria after resumption of the diet.

Authors:  M Bik-Multanowski; B Didycz; R Mozrzymas; M Nowacka; L Kaluzny; W Cichy; B Schneiberg; J Amilkiewicz; A Bilar; M Gizewska; A Lange; E Starostecka; A Chrobot; B I Wojcicka-Bartlomiejczyk; A Milanowski
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

Review 10.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.